SREBF1 and Insulin resistance: Interestingly, Sharawy et al. (2016) have shown that agmatine administration may attenuate insulin resistance through inhibiting SREBP-1c, mammalian target of rapamycin kinase (mTOR) and glucose transporter GLUT-2 in the liver of rats fed a high-fructose diet [21].